Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260299 · ClinicalTrials.gov registry record
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
A clinical trial, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- 1
- Enrollment target
NCT00260299 is a clinical trial that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 1 participants.
The verdict
NCT00260299 was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
Participants wanted for study of mevalonate kinase deficiency (MKD), mevalonic aciduria, or hyperimmunoglobulinemia with periodic fever syndrome (HIDS). Patients with MKD (mevalonic aciduria or hyperimmunoglobulinemia with periodic fever syndrome (HIDS)) may be eligible for a research study conducted at Oregon Health \& Science University (OHSU) in Portland, Oregon USA. The purpose of the study is to find out more about how these diseases affect body chemistry and health. The researchers also want to find out how cholesterol in the diet affect blood cholesterol and how the body handles cholesterol. This is a short-term and long-term dietary study. The long-term goal of this research is to see if controlling dietary cholesterol can decrease any of the symptoms of the diseases. The study could involve up to 12 one-week admissions to OHSU over the course of 5 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2005-02 |
| Est. Completion | 2016-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00260299
The ClinicalTrials.gov registry entry for NCT00260299 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00260299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00260299 about?
NCT00260299 is a clinical study titled "Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency". Participants wanted for study of mevalonate kinase deficiency (MKD), mevalonic aciduria, or hyperimmunoglobulinemia with periodic fever syndrome (HIDS). Patients with MKD (mevalonic aciduria or hyperimmunoglobulinemia with periodic fever syndrome (HIDS)) may be eligible for a research study conduct...
What is the current status of trial NCT00260299?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2005-02. Estimated completion is 2016-01-31.
Who is sponsoring clinical trial NCT00260299?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.